Form 4: Genprex Director Receives 9,000 Restricted Stock Units

Genprex, Inc. Director William R. Wilson Jr. was granted 9,000 Restricted Stock Units, vesting by August 2026.

Summary

• William R. Wilson Jr., a Director of Genprex, Inc. (GNPX), acquired 9,000 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this acquisition was December 22, 2025.
• These RSUs were granted under the Company's 2018 Equity Incentive Plan, as amended and restated effective June 30, 2025.
• The RSUs vest 100% upon the earlier of August 15, 2026, or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, provided the recipient continues to serve as a Service Provider.
• Vested RSUs will be paid in shares of Genprex's common stock, $0.001 par value, on a one-to-one basis.
• Following this transaction, William R. Wilson Jr. beneficially owns 9,157 shares of Common Stock.
• This total beneficial ownership reflects the impact of a 1-for-50 reverse stock split of Genprex's Common Stock, which was effected as of October 21, 2025.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive signal, aligning management's interests with long-term shareholder value. However, the context of a recent 1-for-50 reverse stock split suggests underlying challenges for the company, which tempers the overall sentiment.

Positives

• Director William R. Wilson Jr. received 9,000 Restricted Stock Units, aligning his interests with long-term shareholder value.
• The grant is part of the company's 2018 Equity Incentive Plan, indicating a structured approach to executive compensation and retention.

Risks

• The vesting of the 9,000 Restricted Stock Units is contingent on William R. Wilson Jr. continuing to serve as a Service Provider until the vesting date (earlier of August 15, 2026, or the day prior to the next annual meeting).
• The value of the vested shares is subject to the future market price of Genprex, Inc. common stock.

Future Outlook

The filing indicates a future vesting event for the granted RSUs, contingent on continued service, by August 15, 2026, or earlier.

Industry Context

NA

Stakeholder Impact

• Shareholders: Potential dilution upon vesting of RSUs, but also increased alignment of director's interests with shareholder value. The reverse stock split previously impacted shareholders by consolidating shares.
• Employees: The grant is under an equity incentive plan, which can be a positive for employee morale and retention if similar grants are available.

Next Steps

• Vesting of the 9,000 Restricted Stock Units upon the earlier of August 15, 2026, or the day prior to the Company's next annual meeting of stockholders after the grant date.

Key Dates

Keywords

Genprex, GNPX, Form 4, Restricted Stock Units, RSUs, Equity Incentive Plan, Director Compensation, Insider Transaction, Stock Grant, Reverse Stock Split